	Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer. Oncol Ther Musone M, Barone B, Chianese S, Conforti P, Madonna A, Imperatore S, Dinacci F, Balsamo R, Lucarelli G, Falabella R, Caputo VF, Pastore AL, Fuschi A, Ferro M, Romano L, Fabiano M, Manfredi C, Busetto GM, Santarelli V, Del Giudice F, Crocetto F. PMID: 42277549 [PubMed - as supplied by publisher]
	Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study. Int J Clin Oncol Sugimoto K, Toyoda S, Inoki L, Mori K, Yanagisawa T, Tamura K, Nukaya T, Maenosono R, Morinaka H, Nishimura S, Bekku K, Komura K, Takahara K, Inamoto T, Azuma H, Fujita K, JK-FOOT study group. PMID: 42277542 [PubMed - as supplied by publisher]
	Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradioimmunotherapy for locally advanced esophageal squamous cell carcinoma. Int J Clin Oncol Shi L, Li Y, Li C, Wang X, Cai Q, Cao Y, Teng F, Liao F, Li H, Wang Z. PMID: 42277541 [PubMed - as supplied by publisher]
	Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics. Discov Oncol Rejili M, Farahani N, Alimohammadi M, Hushmandi K. PMID: 42277467 [PubMed - as supplied by publisher]
	Feasibility and acceptability of ExerciseGuideUK for those living with and beyond lung cancer: a mixed methods study. Support Care Cancer Curry J, Pearson M, Short CE, Vandelanotte C, Evans HEL, Lind M, Forbes CC. PMID: 42277446 [PubMed - in process]
	Survival benefit of â¶â¸Ga-FAPI PET/CT staging for prognostic assessment in gastric and colorectal cancer compared with CE-CT and Â¹â¸F-FDG PET/CT: a single-center retrospective study. Eur J Nucl Med Mol Imaging Wu X, Ma L, Zhao Y, Cai G, Wang J, Guo Y, Lu Y, Pan Y, Du X, Nie Y, Kang F, Wang J. PMID: 42277430 [PubMed - as supplied by publisher]
	p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis. Reprod Sci Kobayashi H. PMID: 42277398 [PubMed - as supplied by publisher]
	LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting. Mol Diagn Ther Bonci N, Schiavoni V, Rexha J, Romagnoli A, Campagna R, Tossetta G. PMID: 42277396 [PubMed - as supplied by publisher]
	Educational Interventions to Reduce Cancer Diagnostic Delays in Primary Care: A Scoping Review. J Cancer Educ Jerjes W, Klingbajl M, Taylor A, Majeed A. PMID: 42277388 [PubMed - as supplied by publisher]
	An ultrasound foundation model for the stratification of vision impairment and eye cancer risk. NPJ Digit Med Zhou Z, Chen X, Yu D, Chen Q, Zhang Y, Qian J, Song Q, Guo J, Zhang T, Qian X. PMID: 42277320 [PubMed - as supplied by publisher]
	Quality of life experiences of breast cancer patients undergoing chemotherapy: a descriptive qualitative study from Ayder Comprehensive Specialized Hospital, Ethiopia. Sci Rep Hailu Aregawi D, Berhe Gebru H, Berhe Kahsay H, Kidanu Berhe K, Berhe Y, Abrha S, Buruh Abera G. PMID: 42277263 [PubMed - as supplied by publisher]
	Deep neural architecture empowered by explainable artificial intelligence for accurate and early diagnosis of gynaecological cancer using medical images. Sci Rep Al-Somali SA, AlKubaisy ZM, Rawa M, Allehaibi KH, Alhazmi RM, Ragab M. PMID: 42277262 [PubMed - as supplied by publisher]
	A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance. Sci Rep Alwateer M. PMID: 42277241 [PubMed - as supplied by publisher]
	Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention. Acta Pharmacol Sin Zhao W, Pan JX. PMID: 42277208 [PubMed - as supplied by publisher]
	Development of an Artificial Intelligence Web Application for Predicting Chemotherapy-Induced Neutropenia in Patients With Non-Small Cell Lung Cancer: A Prospective Study. Cancer Med Zhang J, Zhai Y, Liu C, Luo M, Liu J, Liu Q, Zhang H, Cai S, Tian Y, Lu L, Zhang L, Yuan H. PMID: 42276967 [PubMed - in process]
	SEPAR-SECT Recommendations for Perioperative Invasive Mediastinal Staging of Non-small Cell Lung Cancer. Arch Bronconeumol Call S, Botana-Rial M, Cordovilla R, Gálvez C, Gómez de Antonio D, Leiro-Fernández V, Martínez-Barenys C, Recuero-Díaz JL, Sanz-Santos J, Serra-Mitjà P, Rami-Porta R. PMID: 42276952 [PubMed - as supplied by publisher]
	How Will PSMAddition Impact the Management of Prostate Cancer? Eur Urol Focus Marulanda-Corzo V, Holmes AN, Giri VK, Osborne JR, Tagawa ST. PMID: 42276910 [PubMed - as supplied by publisher]
	Fear of Cancer Recurrence in Adolescent and Young Adult Cancer Survivors and Their Caregivers: A Scoping Review. Semin Oncol Nurs Yao Y, Zhao S, Chen X, Li M, Song J, Zhang M, Lei S, Liu S, Niu N. PMID: 42276886 [PubMed - as supplied by publisher]
	Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer. Eur Urol Oncol Josset Q, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Zhou K, Mesgouez-Nebout N, Supiot S. PMID: 42276876 [PubMed - as supplied by publisher]
	Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer. BMJ Open Kagenaar E, Lugo-Palacios DG, Bromley H, Aggarwal A, Hutchings A, O'Neill S, Rachet B, Cresswell J, Choudhury A, Grieve R. PMID: 42276804 [PubMed - in process]

Articles 1 - 20 / 1942565

Page 1 of 97129



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy